Combination Immune Checkpoint Blockade to Reverse HIV Latency
Renée M. Van der Sluis, Nitasha A. Kumar, Rachel D. Pascoe, Jennifer M. Zerbato, Vanessa A. Evans, Ashanti I. Dantanarayana, Jenny L. Anderson, Rafick P. Sékaly, Rémi Fromentin, Nicolas Chomont, Paul U. Cameron and Sharon R. Lewin
J Immunol January 27, 2020, ji1901191; DOI: https://doi.org/10.4049/jimmunol.1901191
Renée M. Van der Sluis
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
Nitasha A. Kumar
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
Rachel D. Pascoe
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
Jennifer M. Zerbato
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
Vanessa A. Evans
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
Ashanti I. Dantanarayana
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
Jenny L. Anderson
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
Rafick P. Sékaly
†Case Western Reserve University, Cleveland, OH 44106;
Rémi Fromentin
‡Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montreal, Quebec H2X 3E4, Canada;
Nicolas Chomont
‡Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montreal, Quebec H2X 3E4, Canada;
§Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Université de Montréal, Montreal, Quebec H3T 1J4, Canada; and
Paul U. Cameron
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
¶Department of Infectious Diseases, Monash University and the Alfred Hospital, Melbourne, Victoria 3000, Australia
Sharon R. Lewin
*The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria 3000, Australia;
¶Department of Infectious Diseases, Monash University and the Alfred Hospital, Melbourne, Victoria 3000, Australia